Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Daojun Pharmaceutical is a mid-sized private pharmaceutical company based in Baicheng, Jilin Province, China. Established in 1998, the company integrates drug trade, retail chains, research and development, and manufacturing into its core business operations. Its comprehensive product portfolio encompasses both traditional Chinese medicine (TCM) and Western chemical generics, covering therapeutic areas such as inflammation, infectious diseases, and metabolic disorders. The company operates multiple GMP-certified production lines for solid dosage forms, including tablets, capsules, granules, and pills. Recognized as a National High-Tech Enterprise, Jilin Daojun Pharmaceutical focuses on delivering established treatments to the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Daojun Pharmaceutical.